CV Sciences Revenue and Competitors

Location

$2M

Total Funding

Cannabis

Industry

Estimated Revenue & Valuation

  • CV Sciences's estimated annual revenue is currently $16.8M per year.(i)
  • CV Sciences's estimated revenue per employee is $243,000
  • CV Sciences's total funding is $2M.

Employee Data

  • CV Sciences has 69 Employees.(i)
  • CV Sciences grew their employee count by -1% last year.

CV Sciences's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP SalesReveal Email/Phone
3
SVP & Scientific & Regulatory AffairsReveal Email/Phone
4
Chief Financial Officer (CFO)Reveal Email/Phone
5
Director Sales OperationsReveal Email/Phone
6
Associate Director EcommerceReveal Email/Phone
7
Creative DirectorReveal Email/Phone
8
Director OperationsReveal Email/Phone
9
Senior Marketing Project ManagerReveal Email/Phone
10
Supply Chain ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$71.9M4115%N/AN/A
Add Company

What Is CV Sciences?

CV Sciences: Integrating Science and Nature, Improving Health and Well-being CV Sciences, Inc., a life sciences organization, is focused on promoting healthy living through their pharmaceutical drug development efforts and portfolio of finished product brands. Makers of PlusCBD Oil, the leading brand in hemp-derived CBD oil products available online, in health food stores, and practitioners offices nationwide. At CV Sciences, our mission is to make healthy people healthier. Our dedication to consumer well-being underscores our values, operations, and products.

keywords:N/A

$2M

Total Funding

69

Number of Employees

$16.8M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CV Sciences News

2022-04-06 - Faruqi & Faruqi, LLP Announces Proposed Settlement Of In Re CV ...

NEW YORK, April 11, 2022 /PRNewswire/ --. UNITED STATES DISTRICT COURT DISTRICT OF NEVADA. In re: CV SCIENCES, INC. SECURITIES LITIGATION.

2022-03-30 - CV SCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)

CV SCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) · December 31, 2021 , our...

2022-03-30 - CV Sciences, Inc. Reports Fiscal Year-End 2021 Financial Results

(OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products,...

2019-09-08 - CV Sciences, Inc. CEO Issues Letter to Shareholders

SAN DIEGO, Aug. 12, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.6M6917%N/A
#2
$15.8M69-4%N/A
#3
$18M698%N/A
#4
$12.7M6950%N/A
#5
$14.1M6925%N/A